Literature DB >> 21145113

Adiponectin and IGF-1 are negative acute phase proteins in a dog model of acute endotoxaemia.

Asta Tvarijonaviciute1, Oya Eralp, Meric Kocaturk, Zeki Yilmaz, Jose J Ceron.   

Abstract

The objective of this study was to evaluate the influence of an experimentally induced acute inflammation on serum adiponectin and insulin-like growth factor 1 (IGF-1) levels in the dog, and to compare their evolution with other well-established acute phase proteins (APPs) such as C-reactive protein (CRP), and haptoglobin (Hp). Therefore levels of adiponectin, IGF-1 and a profile of APPs were measured in healthy dogs after intravenous administration of E. coli LPS (0.02 mg/kg) and compared with dogs injected with saline solution (0.2 mL/kg). Adiponectin and IGF-1 were both decreased in response to endotoxins in the dog. Significant positive correlations were found between adiponectin and IGF-1 (r=0.31; p<0.05). Adiponectin had also a significant negative correlation with CRP (r=-0.39; p<0.05) and Hp (r=-0.27; p<0.05), whereas IGF-1 had significant negative correlation with CRP (r=-0.52; p<0.001). The results obtained in the present study indicate that adiponectin and IGF-1 behave as negative acute phase proteins after acute inflammatory stimulus in dogs.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145113     DOI: 10.1016/j.vetimm.2010.11.011

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  8 in total

1.  Obesity and IL-6 interact in modulating the response to endotoxemia in mice.

Authors:  Maria Pini; Karla J Castellanos; Davina H Rhodes; Giamila Fantuzzi
Journal:  Cytokine       Date:  2012-09-23       Impact factor: 3.861

2.  Serum Proteomic Changes in Dogs with Different Stages of Chronic Heart Failure.

Authors:  Ahmet Saril; Meric Kocaturk; Kazumi Shimada; Akiko Uemura; Emel Akgün; Pinar Levent; Ahmet Tarik Baykal; Alberto Muñoz Prieto; Carlos Fernando Agudelo; Ryou Tanaka; Jose Joaquin Ceron; Jorgen Koch; Zeki Yilmaz
Journal:  Animals (Basel)       Date:  2022-02-16       Impact factor: 2.752

3.  Insulin-like Growth Factor 1 and Adiponectin and Associations with Muscle Deficits, Disease Characteristics, and Treatments in Rheumatoid Arthritis.

Authors:  Joshua F Baker; Joan Marie Von Feldt; Sogol Mostoufi-Moab; Woojin Kim; Elena Taratuta; Mary B Leonard
Journal:  J Rheumatol       Date:  2015-09-01       Impact factor: 4.666

4.  Insulin-like growth factor 1 opposes the effects of C-reactive protein on endothelial cell activation.

Authors:  Shao-Jun Liu; Yun Zhong; Xiang-Yu You; Wei-Hua Liu; Ai-Qun Li; Shi-Ming Liu
Journal:  Mol Cell Biochem       Date:  2013-09-25       Impact factor: 3.396

Review 5.  The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cells.

Authors:  D H Lewis; D L Chan; D Pinheiro; E Armitage-Chan; O A Garden
Journal:  J Vet Intern Med       Date:  2012-03-17       Impact factor: 3.333

6.  Allergy, inflammation, hepatopathy and coagulation biomarkers in dogs with suspected anaphylaxis due to insect envenomation.

Authors:  Kate Turner; Corrin Boyd; Gabriele Rossi; Claire R Sharp; Melissa A Claus; Abbie Francis; Lisa Smart
Journal:  Front Vet Sci       Date:  2022-08-08

7.  Changes in Plasma Adiponectin Concentrations in Patients With Hemorrhagic Fever With Renal Syndrome: An Observational Prospective Study.

Authors:  Hong Du; Xuefan Bai; Jianqi Lian; Jing Li; Ying Zhang; Pingzhong Wang; Hong Jiang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

8.  Age-Dependent Changes of Adipokine and Cytokine Secretion From Rat Adipose Tissue by Endogenous and Exogenous Toll-Like Receptor Agonists.

Authors:  Verena Peek; Elena Neumann; Tomohiro Inoue; Sandy Koenig; Fabian Johannes Pflieger; Rüdiger Gerstberger; Joachim Roth; Kiyoshi Matsumura; Christoph Rummel
Journal:  Front Immunol       Date:  2020-08-19       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.